Tofacitinib Tofajak XR Tablets 11mg

Get a Price/Quote

MOQ : 10 Pieces

Tofacitinib Tofajak XR Tablets 11mg Specification

Origin of Medicine
India

Indication
Rheumatoid arthritis, Psoriatic arthritis, Ulcerative colitis

Salt Composition
Tofacitinib 11 mg

Brand Name
Tofajak XR

Pacakaging (Quantity Per Box)
10 Tablets

Dosage Form
Extended Release Tablet

Life Span
Refer to pack for expiry date

Packaging Type
Box/Blister pack

Drug Type
Allopathic

Ingredients
Tofacitinib

Physical Form
Tablet

Function
JAK inhibitor for immunomodulatory therapy

Recommended For
Adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis, as prescribed by physician

Dosage
As directed by the physician, commonly 11 mg once daily

Dosage Guidelines
Take with or without food, swallow whole with water, do not crush or chew

Suitable For
Adults

Quantity
10 Tablets per box

Storage Instructions
Store below 30C, protect from moisture and light

Prescription Status
Prescription only (Rx)

Extended Release
Yes

Tablet Color
White (as per image)

Country of Approval
Recognized in Canada, EU, UK, USA, Australia (as per image flags)

Administration Route
Oral

Therapeutic Class
Immunosuppressant/Antirheumatic

Tablet Shape
Oblong (as per packaging style)

Tofacitinib Tofajak XR Tablets 11mg About

Ending Soon: Reserve your supply of the sizzling Tofacitinib Tofajak XR Tablets 11mg-an exceptional extended-release oral prescription for adults. Designed as a stellar immunosuppressant and antirheumatic, this masterpiece delivers targeted JAK inhibitor therapy for rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis. Produced in India and approved across Canada, EU, UK, USA, and Australia, each white, oblong tablet ensures consistent, effective relief. With 10 tablets per box, Tofajak XR is recommended for use as directed by your physician. Don't miss your chance to experience extraordinary support-reserve yours today!

Key Applications and General Use of Tofacitinib Tofajak XR

Tofacitinib Tofajak XR Tablets 11mg are specifically formulated for adult patients requiring advanced immunomodulatory therapy. Their primary application lies in managing moderate to severe cases of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. As an extended-release option, they provide steady therapeutic levels, making them suitable for continuous daily use. The general use is under strict physician guidance, ensuring maximum benefit for individuals with autoimmune inflammatory disorders.

Packaging & Export Details for Global Markets

Each offer comes in a secure box or blister pack containing 10 oblong, white tablets. Shipments are dispatched promptly from India to major export markets, including Canada, the EU, UK, USA, and Australia. Our FOB port operations ensure high-quality handling and timely delivery. Proposal amounts, shipment logistics, and special export requests are managed efficiently, catering to manufacturers, suppliers, and traders around the world seeking trusted pharmaceutical solutions.

FAQ's of Tofacitinib Tofajak XR Tablets 11mg:

Q: How should Tofacitinib Tofajak XR Tablets 11mg be administered for optimal results?

A: Take one extended-release tablet orally once daily, exactly as prescribed by your physician. Swallow the tablet whole with water-do not crush, chew, or break it. It can be taken with or without food.

Q: What makes Tofajak XR an exceptional option for rheumatoid arthritis and related conditions?

A: Tofajak XR utilizes Tofacitinib, a potent JAK inhibitor, in an extended-release formula for sustained immunomodulatory effects, providing effective symptom relief in rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

Q: When can patients expect the shipment to reach main export destinations?

A: Upon confirmation, shipments are processed promptly from India. Delivery times depend on the destination, typically reaching Canada, EU, UK, USA, or Australia within the quoted timeline following the finalized proposal amount.

Q: Where is Tofajak XR approved and where can it be exported?

A: Tofajak XR tablets are recognized and approved in Canada, the EU, UK, USA, and Australia. The product is available for export to these and other eligible markets as per regulatory norms.

Q: What is the recommended storage process for Tofacitinib Tofajak XR Tablets?

A: Store the tablets below 30C, protected from moisture and light. Always keep them in their original packaging until use, and check the lifespan as indicated on the pack.

Q: What is the main benefit of the extended-release formulation in Tofajak XR tablets?

A: The extended-release design ensures a steady release of medication throughout the day, providing consistent therapeutic effects and improved symptom management for adults with chronic inflammatory conditions.

Tell us about your requirement